vs
PLAYSTUDIOS, Inc.（MYPS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是PLAYSTUDIOS, Inc.的1.3倍（$69.8M vs $55.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -24.7%，领先408.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -18.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -15.6%）
PLAYSTUDIOS是一家专注于开发发行免费社交及休闲博彩游戏的企业，产品覆盖移动端、桌面端及社交平台。其独有奖励体系支持玩家将游戏成就兑换为住宿、餐饮、演出门票等实体福利，业务覆盖全球多个主要市场。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MYPS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$55.4M
营收增速更快
RIGL
高出39.5%
-18.3%
净利率更高
RIGL
高出408.8%
-24.7%
两年增速更快
RIGL
近两年复合增速
-15.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.4M | $69.8M |
| 净利润 | $-13.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -17.7% | 33.2% |
| 净利率 | -24.7% | 384.0% |
| 营收同比 | -18.3% | 21.2% |
| 净利润同比 | 38.9% | 1769.2% |
| 每股收益（稀释后） | $-0.12 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MYPSRIGL
| Q4 25 | $55.4M | $69.8M | ||
| Q3 25 | $57.6M | $69.5M | ||
| Q2 25 | $59.3M | $101.7M | ||
| Q1 25 | $62.7M | $53.3M | ||
| Q4 24 | $67.8M | $57.6M | ||
| Q3 24 | $71.2M | $55.3M | ||
| Q2 24 | $72.6M | $36.8M | ||
| Q1 24 | $77.8M | $29.5M |
净利润MYPSRIGL
| Q4 25 | $-13.7M | $268.1M | ||
| Q3 25 | $-9.1M | $27.9M | ||
| Q2 25 | $-2.9M | $59.6M | ||
| Q1 25 | $-2.9M | $11.4M | ||
| Q4 24 | $-22.4M | $14.3M | ||
| Q3 24 | $-3.1M | $12.4M | ||
| Q2 24 | $-2.6M | $-1.0M | ||
| Q1 24 | $-567.0K | $-8.2M |
毛利率MYPSRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率MYPSRIGL
| Q4 25 | -17.7% | 33.2% | ||
| Q3 25 | -13.6% | 40.9% | ||
| Q2 25 | -5.9% | 60.1% | ||
| Q1 25 | -4.4% | 23.9% | ||
| Q4 24 | -33.1% | 28.9% | ||
| Q3 24 | -6.7% | 25.4% | ||
| Q2 24 | -5.5% | 1.2% | ||
| Q1 24 | -2.2% | -23.6% |
净利率MYPSRIGL
| Q4 25 | -24.7% | 384.0% | ||
| Q3 25 | -15.8% | 40.2% | ||
| Q2 25 | -5.0% | 58.6% | ||
| Q1 25 | -4.6% | 21.5% | ||
| Q4 24 | -33.1% | 24.9% | ||
| Q3 24 | -4.3% | 22.5% | ||
| Q2 24 | -3.6% | -2.8% | ||
| Q1 24 | -0.7% | -27.9% |
每股收益（稀释后）MYPSRIGL
| Q4 25 | $-0.12 | $14.11 | ||
| Q3 25 | $-0.07 | $1.46 | ||
| Q2 25 | $-0.02 | $3.28 | ||
| Q1 25 | $-0.02 | $0.63 | ||
| Q4 24 | $-0.18 | $0.82 | ||
| Q3 24 | $-0.02 | $0.70 | ||
| Q2 24 | $-0.02 | $-0.06 | ||
| Q1 24 | $0.00 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $104.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $227.9M | $391.5M |
| 总资产 | $290.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MYPSRIGL
| Q4 25 | $104.9M | $155.0M | ||
| Q3 25 | $106.3M | $137.1M | ||
| Q2 25 | $112.9M | $108.4M | ||
| Q1 25 | $107.1M | $77.1M | ||
| Q4 24 | $109.2M | $77.3M | ||
| Q3 24 | $105.2M | $61.1M | ||
| Q2 24 | $106.3M | $49.1M | ||
| Q1 24 | $127.0M | $49.5M |
总债务MYPSRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益MYPSRIGL
| Q4 25 | $227.9M | $391.5M | ||
| Q3 25 | $238.9M | $117.6M | ||
| Q2 25 | $245.3M | $81.9M | ||
| Q1 25 | $244.1M | $18.6M | ||
| Q4 24 | $244.7M | $3.3M | ||
| Q3 24 | $265.2M | $-14.6M | ||
| Q2 24 | $263.6M | $-29.9M | ||
| Q1 24 | $288.4M | $-31.7M |
总资产MYPSRIGL
| Q4 25 | $290.6M | $513.6M | ||
| Q3 25 | $299.2M | $242.5M | ||
| Q2 25 | $316.2M | $206.7M | ||
| Q1 25 | $313.8M | $176.0M | ||
| Q4 24 | $323.0M | $164.0M | ||
| Q3 24 | $330.6M | $139.4M | ||
| Q2 24 | $333.4M | $128.4M | ||
| Q1 24 | $357.5M | $126.5M |
负债/权益比MYPSRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $3.6M | — |
| 自由现金流率自由现金流/营收 | 6.5% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $25.4M | — |
8季度趋势，按日历期对齐
经营现金流MYPSRIGL
| Q4 25 | $3.7M | $22.0M | ||
| Q3 25 | $5.7M | $24.0M | ||
| Q2 25 | $13.6M | $30.5M | ||
| Q1 25 | $3.3M | $-893.0K | ||
| Q4 24 | $11.6M | $14.5M | ||
| Q3 24 | $14.6M | $21.7M | ||
| Q2 24 | $14.5M | $302.0K | ||
| Q1 24 | $5.0M | $-5.0M |
自由现金流MYPSRIGL
| Q4 25 | $3.6M | — | ||
| Q3 25 | $5.4M | — | ||
| Q2 25 | $13.2M | — | ||
| Q1 25 | $3.2M | — | ||
| Q4 24 | $11.5M | — | ||
| Q3 24 | $13.9M | — | ||
| Q2 24 | $12.8M | — | ||
| Q1 24 | $3.6M | — |
自由现金流率MYPSRIGL
| Q4 25 | 6.5% | — | ||
| Q3 25 | 9.3% | — | ||
| Q2 25 | 22.3% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 16.9% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 17.6% | — | ||
| Q1 24 | 4.6% | — |
资本支出强度MYPSRIGL
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 1.9% | — |
现金转化率MYPSRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
